Earth Science Tech Inc (OTCMKTS:ETST) is a penny play that has really started to garner attention as the stock bounces up the chart. Shares have caught fire in the past week, blasting 200% higher in a move that represents both a technical breakout and a reaction to recent catalysts: For example, the company just announced that it has signed a joint venture agreement with an established nutritional supplement company, Nutrition Specialties and its division Forzagen, which will secure a foothold for the company in the multi-billion dollar sports supplement industry.
According to the company’s most recent press release, Earth Science Tech will share research, development, and manufacturing spaces with Nutrition Specialties and Forzagen in order to explore various expertise synergies. President & COO, Nickolas Tabraue, will work with Nutrition Specialties and Forzagen to develop new, full-spectrum cannabis-based (Industrial Hemp) sports supplements and instantly enter the sports supplement industry both domestically and internationally.
Earth Science Tech Inc (OTCMKTS:ETST) bills itself as a unique Biotechnology company focused on delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine and to improving the quality of life for Consumers Worldwide.
ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. This may include products such as CBD (Cannabidiol) as a natural constituent of Hemp Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products.
These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
According to company materials, “Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (Sexually Transmitted Infections and/or Diseases), as well developing new advanced formulated cannabis CBD nutraceuticals and 2 Cannabis CBD-based pharmaceutical drugs under its cannabis CBD patent, IP and technology. Earth Science Pharmaceutical CEO, Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.”
Find out when $ETST stock reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As they frame the new strategic arrangement in communications, ETST will provide its formulation, marketing, branding, sales, and supply services to Nutrition Specialties and Forzagen in exchange for connections to international distributors in the supplement industry. Nutrition Specialties and Forzagen have existing international contracts with large brands such as Costco and Sam’s Club. Additionally, all new products developed with Earth Science Tech’s CBD ingredients will include the company’s logo on its packaging, which will help create brand awareness to the large audiences that these big brands service.
“This partnership is enormous for both of our companies. We can provide our cannabis industry expertise, cannabinoid research and development, supply, and formulation services to Nutrition Specialties and Forzagen, and they can provide us with access to cutting edge sports science knowledge, a leading lab team, and a much larger supply chain than we have ever been involved with,” said Mr. Tabraue, “This could be a vast driving force for us that really springboards our company to the next level as a pioneer in the cannabis (CBD Industrial Hemp) sports supplement industry.”
The chart shows above 150% added to share values of the listing over the past month of action. This is emblematic of the stock. ETST has evidenced sudden upward volatility on many prior occasions. Furthermore, the stock has seen an influx in interest of late, with the stock’s recent average trading volume running nearly 560% beyond what we have been seeing over the larger time frame.
It pays to take note of this fact with a float in play that’s extremely small — of 15.1M shares. As savvy traders are well aware, with such a tight trading float, this kind of ramping interest can force a supply-shock squeeze.
Now commanding a market cap of $44.2M, ETST has virtually no cash on the books, which is balanced by virtually no total current liabilities. ETST is pulling in trailing 12-month revenues of $496K. However, the company is seeing declines on the top line on a quarterly y/y basis, with revenues falling at -28.5%. You can bet we will update this one again as new information comes into view. For continuing coverage on shares of $ETST stock, as well as our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!
